Back
Verisk Analytics Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
73
VRSK
Verisk Analytics
Last Price:
$302.16
Seasonality Move:
5.73%
Sell
50
RYTM
Rhythm Pharmaceuticals
Last Price:
$59.09
Seasonality Move:
54.9%
Buy
73
Verisk Analytics (VRSK)
is a Buy
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $303.65. The Score for VRSK is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
VRSK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $58.97. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $303.65The current trend is moderately bullish and VRSK is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $58.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.
VRSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.9 | Buy |
Relative Strength Index (14 RSI): | 57.76 | Buy |
Chaikin Money Flow: | -453587 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (284.93 - 301.17) | Buy |
Bollinger Bands (100): | (279.36 - 297.28) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 46.88 | Sell |
Chaikin Money Flow: | 27337 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.61 - 64.05) | Sell |
Bollinger Bands (100): | (52.9 - 60.74) | Buy |
VRSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 301.28 | Buy |
20-day SMA: | 295.21 | Buy |
50-day SMA: | 293.17 | Buy |
200-day SMA: | 281.09 | Buy |
8-day EMA: | 302.22 | Buy |
20-day EMA: | 297.22 | Buy |
50-day EMA: | 293.36 | Buy |
200-day EMA: | 280.45 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.08 | Sell |
20-day SMA: | 62.15 | Sell |
50-day SMA: | 56.78 | Buy |
200-day SMA: | 54.27 | Buy |
8-day EMA: | 61.17 | Sell |
20-day EMA: | 61 | Sell |
50-day EMA: | 58.76 | Buy |
200-day EMA: | 53.68 | Buy |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.21 per share, an increase this year of $0.42 per share, and an increase next year of $0.86 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
Verisk Analytics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |